Canaccord Genuity Maintains a 'Buy' on AngioDynamics (ANGO); Q3 Preview
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.75 -0.44%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on AngioDynamics (NASDAQ: ANGO) price target of $16.50.
Analyst, Jason R. Mills, said, "ANGO reports FQ3 on April 4, and we expect in-line results (sees $0.07/$50.6mln)...We believe the focus of the call will be on updates to the Navilyst acquisition, which, while dilutive near term has the potential to drive EBITDA upside in out years via revenue and cost synergies."
Mills said that he was unerwhelmed by the Navilyst deal, but the risk/reward is still favorable and suggests investors start building positions in the stock at the $12-13 range.
For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.
Shares of AngioDynamics closed at $12.27 yesterday.
Analyst, Jason R. Mills, said, "ANGO reports FQ3 on April 4, and we expect in-line results (sees $0.07/$50.6mln)...We believe the focus of the call will be on updates to the Navilyst acquisition, which, while dilutive near term has the potential to drive EBITDA upside in out years via revenue and cost synergies."
Mills said that he was unerwhelmed by the Navilyst deal, but the risk/reward is still favorable and suggests investors start building positions in the stock at the $12-13 range.
For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.
Shares of AngioDynamics closed at $12.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
- Deere (DE) PT Raised to $585 at JPMorgan
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
